BUSINESS● LOWOct 6 · Oct 6, 2026, 4:25 AM
Spyre Therapeutics prices $350M public offering at $85 per share
Seeking Alpha Tech · global
Spyre Therapeutics has set the price for its $350 million public offering at $85 per share. This indicates a significant financial move by the company to raise capital.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS36m agoBelagavi-based Aequs announces long-term supply agreements with Safran for aerospace applicationsThe HinduBUSINESS49m agoDeepening tech sell-off drags stocks lower as major markets slideEuroNews [en]